Hydroxychloroquine: all 337 studies that test it

Page 3 of 4. Open to participants first (40), then studies with results posted, then the rest; newest registration first within each.

• Efficacay of Chloroquine or Hydroxychloroquine in COVID-19 TreatmentCompletedNCT04353336Phase 2/3
• Assessment of Efficacy and Safety of HCQ and Antibiotics Administrated to Patients COVID19(+)WithdrawnNCT04351919Phase 4
• Austrian CoronaVirus Adaptive Clinical Trial (COVID-19)Status unknownNCT04351724Phase 2/3
• High-dose Hydroxychloroquine for the Treatment of Ambulatory Patients With Mild COVID-19CompletedNCT04351620Phase 1
• Test and Treat COVID 65plus+WithdrawnNCT04351516Phase 2/3
• Hydroxychloroquine Treatment of Healthcare Workers With COVID19 Illness at MontefioreWithdrawnNCT04350450Phase 2
• Hydroxychloroquine With or Without Azithromycin for Virologic Cure of COVID-19CompletedNCT04349592Not applicable
• The Fleming [FMTVDM] Directed CoVid-19 Treatment ProtocolCompletedNCT04349410Phase 2/3
• Assessment of the Efficacy and Safety of (HCQ) as a Prophylaxis for COVID19 for Health ProfessionalsWithdrawnNCT04349228Phase 3
• Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Ambulatory Patients With Mild COVID-19SuspendedNCT04348474Early Phase 1
• Dexamethasone Treatment for Severe Acute Respiratory Distress Syndrome Induced by COVID-19TerminatedNCT04347980Phase 3
• Preventing COVID-19 in Healthcare Workers With HCQ: A RCTWithdrawnNCT04347889Phase 2
• EVALUATION OF THE EFFICACY OF THE HYDROXYCHLOROQUINE-AZITHROMYCIN COMBINATION IN THE IN THE PREVENTION OF COVID-19 RELATED SDRAWithdrawnNCT04347512Phase 3
• A Study of the Effectiveness of an Off Label Mefloquine Use for the Treatment of Patients With COVID19CompletedNCT04347031Phase 2/3
• Immune Monitoring of Prophylactic Effect of Hydroxychloroquine in Healthcare Providers Highly Exposed to COVID-19WithdrawnNCT04346329Phase 3
• Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for COVID-19 Pneumonia (COVIDOC Trial)TerminatedNCT04345861Phase 2/3
• A Randomized Controlled Clinical Trial: Hydroxychloroquine for the Treatment of COVID-19 in Hospitalized PatientsTerminatedNCT04345692Phase 3
• Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19Status unknownNCT04344457Phase 1/2
• Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe DiseaseTerminatedNCT04344444Phase 3
• Hydroxychloroquine for COVID-19TerminatedNCT04342221Phase 3
• Study of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients: Sarilumab, Azithromycin, Hydroxychloroquine Trial - CORIMUNO-19 - VIROSuspendedNCT04341870Phase 2/3
• Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease in French Cancer PatientsStatus unknownNCT04341207Phase 2
• Hydroxychloroquine for the Treatment of Mild COVID-19 DiseaseTerminatedNCT04340544Phase 2
• Low-dose Hydroxychloroquine and Bromhexine: a Novel Regimen for COVID-19 Prophylaxis in Healthcare ProfessionalsStatus unknownNCT04340349Early Phase 1
• Azithromycin Added to Hydrochloroquine in Patients Admitted to Intensive Care With COVID-19: Randomised Controlled TrialTerminatedNCT04339816Phase 3
• Hydroxychloroquine, Oseltamivir and Azithromycin for the Treatment of COVID-19 Infection: An RCTCompletedNCT04338698Phase 3
• HCQ for Primary Prophylaxis Against COVID19 in Health-care WorkersWithdrawnNCT04336748Phase 3
• A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 InfectionCompletedNCT04335084Phase 2
• Hydroxychloroquine in Patients With Newly Diagnosed COVID-19 Compared to Standard of CareSuspendedNCT04334967Phase 4
• Randomized Clinical Trial for the Prevention of SARS-CoV-2 Infection (COVID-19) in Healthcare PersonnelCompletedNCT04334928Phase 3
• A Study of Quintuple Therapy to Treat COVID-19 InfectionCompletedNCT04334512Phase 2
• Hydroxychloroquine vs. Azithromycin for Outpatients in Utah With COVID-19Status unknownNCT04334382Phase 3
• Hydroxychloroquine in Outpatient Adults With COVID-19TerminatedNCT04333654Phase 1
• Pre-Exposure Prophylaxis With Hydroxychloroquine for High-Risk Healthcare Workers During the COVID-19 PandemicCompletedNCT04331834Phase 3
• ALBERTA HOPE COVID-19 for the Prevention of Severe COVID19 DiseaseTerminatedNCT04329611Phase 3
• Efficacy and Safety of Hydroxychloroquine and Azithromycin for Patients With Moderate to Severe COVID-19SuspendedNCT04329572Early Phase 1
• Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare WorkersTerminatedNCT04328285Phase 3
• Effectiveness of Hydroxychloroquine in Covid-19 PatientsStatus unknownNCT04328272Phase 3
• Hydroxychloroquine Versus Placebo in COVID-19 Patients at Risk for Severe DiseaseTerminatedNCT04325893Phase 3
• Hydroxychloroquine for the Treatment of Patients With Mild to Moderate COVID-19 to Prevent Progression to Severe Infection or DeathWithdrawnNCT04323631Early Phase 1
• Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-Cov-2 Virus (COVID-19)CompletedNCT04322123Phase 3
• The Efficacy of Different Anti-viral Drugs in COVID 19 Infected PatientsStatus unknownNCT04321616Phase 2/3
• Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II)CompletedNCT04321278Phase 3
• Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial)CompletedNCT04318015Phase 3
• Hydroxychloroquine in ANCA Vasculitis EvaluationTerminatedNCT04316494Phase 4
• Norwegian Coronavirus Disease 2019 StudyStatus unknownNCT04316377Phase 4
• Hydroxychloroquine, Abemaciclib and Endocrine Therapy in Hormone Receptor Positive (HR+)/Her 2 Negative Breast CancerWithdrawnNCT04316169Phase 1
• Trial of Treatments for COVID-19 in Hospitalized AdultsCompletedNCT04315948Phase 3
• Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial)CompletedNCT04315896Phase 3
• Chloroquine/ Hydroxychloroquine Prevention of Coronavirus Disease (COVID-19) in the Healthcare SettingCompletedNCT04303507Not applicable
• HYDROxychloroquine in Syndrome Primary AntiPhospholipidWithdrawnNCT04275778Phase 2
• Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19CompletedNCT04261517Phase 3
• Hydroxychloroquine and Unexplained Recurrent MiscarriageCompletedNCT04228263Not applicable
• Combined Carfilzomib and Hydroxychloroquine in Patients With Relapsed/Refractory Multiple MyelomaCompletedNCT04163107Phase 1
• Anti-Inflammatory Drug and Endothelial FunctionStatus unknownNCT04161339Phase 4
• Hydroxychloroquine for Thrombosis Prevention and Antiphospholipid Antibody Reduction in Primary Antiphospholipid SyndromeCompletedNCT04153201Not applicable
• Ulixertinib (BVD-523) and Hydroxychloroquine in Patients W Advanced MAPK-Mutated Gastrointestinal AdenocarcinomasCompletedNCT04145297Phase 1
• Binimetinib and Hydroxychloroquine in Treating Patients With KRAS Mutant Metastatic Pancreatic CancerCompletedNCT04132505Phase 1
• Oral Hydroxychloroquine (HCQ) for Retinitis Pigmentosa Caused by P23H- Rhodopsin (RHO)TerminatedNCT04120883Phase 1/2
• Hydroxychloroquine Efficacy on Behcet's Disease ThrombosisStatus unknownNCT04022421Not applicable
• Effect of Bitter in Overweight Female VolunteersStatus unknownNCT04005781Phase 4
• Effect of Hydroxychloroquine Sulphate in Healthy Lean FemalesStatus unknownNCT04005768Phase 4
• CPI-613 and Hydroxychloroquine for Patients With High Risk Myelodysplastic SyndromeWithdrawnNCT03929211Phase 1/2
• Hydroxychloroquine Administration for Reduction of PexophagyCompletedNCT03856866Phase 2
• Trametinib and Hydroxychloroquine in Treating Patients With Pancreatic CancerTerminatedNCT03825289Phase 1
• Dabrafenib/Trametinib/Hydroxychloroquine for Advanced Pretreated BRAF V600 Mutant MelanomaStatus unknownNCT03754179Phase 1/2
• Immunosuppressant Regimens for Living Fetuses StudyStatus unknownNCT03671174Not applicable
• Gemcitabine, Docetaxel, and Hydroxychloroquine in Treating Participants With Recurrent or Refractory OsteosarcomaActive, not recruitingNCT03598595Phase 1/2
• Effect of Hydroxychloroquine on Atrial Fibrillation RecurrenceStatus unknownNCT03592823Phase 4
• Hydroxychloroquine Versus Placebo: Impact on Thrombotic Relapse in Primary Antiphospholipid SyndromeStatus unknownNCT03540810Phase 3
• Phase I/II Study of Hydroxychloroquine With Itraconazole With Biochemically Recurrent Prostate CancerCompletedNCT03513211Phase 1/2
• Gedatolisib, Hydroxychloroquine or the Combination for Prevention of Recurrent Breast Cancer ("GLACIER")WithdrawnNCT03400254Phase 1/2
• A Study of ABC294640 Alone and in Combination With HCQ Sulfate in the Treatment of Advanced CholangiocarcinomaCompletedNCT03377179Phase 2
• Hydroxychloroquine (HCQ) for Recurrent Pregnancy LossStatus unknownNCT03305263Phase 3
• Reposition of Second Line Treatment in Chronic Immune ThrombocytopeniaCompletedNCT03229746Phase 4
• Hydroxychloroquine for Prevention of Recurrent Miscarriage.Active, not recruitingNCT03165136Phase 3
• Role of Hydroxychloroquine to Improve Endothelial Dysfunction in Patients With Rheumatoid ArthritisCompletedNCT03085940Not applicable
• A Study of the Safety, Tolerability and Effectiveness of Hydroxychloroquine and Itraconazole in Platinum-resistant Epithelial Ovarian CancerCompletedNCT03081702Phase 1/2
• Biological Effects of Agent on PAR-4 Levels With Resected Solid TumorsCompletedNCT03015324Phase 1
• A Study of Hydroxychloroquine Sulfate for Reduction of Proteinuria in Patients With IgA NephropathyCompletedNCT02942381Phase 2
• Hydroxychloroquine in Primary Progressive Multiple SclerosisCompletedNCT02913157Phase 2
• The Influence of Plaquenil/Hydroxychloroquine (HCQ) on Insulin SecretionStatus unknownNCT02910076Phase 1/2
• Efficacy Study of Hydroxychloroquine to Treat High-risk Coronary Artery Disease.CompletedNCT02874287Phase 4
• Prediction of Relapse Risk in Stable Systemic Lupus ErythematosusCompletedNCT02842814Not applicable
• Hydroxychloroquine Sulfate Alleviates Persistent Proteinuria in IgA NephropathyStatus unknownNCT02765594Phase 4
• Circulating MicroRNAs in Understanding Pathogenesis of Systemic Lupus ErythematosisCompletedNCT02756546Phase 1/2
• STUDY 15 - Comparing Gemcitabine/Carboplatin and Hydroxychloroquine Versus Carboplatin/Etoposide Therapy Alone in Small Cell Lung Cancer (SCLC)TerminatedNCT02722369Phase 2
• Hydroxychloroquine for the Prevention of Cardiovascular Events in Myocardial Infarction Patients - a Safety Pilot TrialCompletedNCT02648464Phase 4
• Comparison of Combination Disease Modifying Antirheumatic Drugs With Methotrexate Therapy in Early Rheumatoid ArthritisCompletedNCT02644499Phase 4
• Phase I Study of Mitoxantrone and Etoposide Combined With Hydroxychloroquine, for Relapsed Acute Myelogenous LeukemiaTerminatedNCT02631252Phase 1
• Study of the Efficiency of Hydroxychloroquine on the Endothelial Dysfunction and Its Vascular Consequences During the Antiphospholipid SyndromeTerminatedNCT02595346Phase 2
• Efficacy of VHM After Treatment Interruption in Subjects Initiating ART During Acute HIV InfectionCompletedNCT02475915Phase 1/2
• Hydroxychloroquine in Blocking Autophagy in Patients With Prostate Cancer Undergoing Surgery or Active SurveillanceTerminatedNCT02421575Early Phase 1
• Hydroxychloroquine in Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Hormonal TherapyTerminatedNCT02414776Phase 1
• Hydroxychloroquine (HCQ) for Recurrent Pregnancy LossWithdrawnNCT02379650Phase 2
• Hydroxychloroquine Sulfate for Reduction of Proteinuria in Patients With IgA Nephropathy: a Self- Controlled StudyCompletedNCT02351752Phase 4
• Combination Therapy Prevents the Relapse of RAStatus unknownNCT02320630Not applicable
• Dabrafenib, Trametinib and Hydroxychloroquine in Patients With Advanced BRAF Mutant MelanomaCompletedNCT02257424Phase 1/2
• Hydroxychloroquine as Steroid-Sparing Agent in Pulmonary Sarcoidosis (HySSAS).CompletedNCT02200146Phase 3
• The Effect of Plaquenil on Serum Inflammatory Markers and Goiter in Euthyroid Young Women With Hashimoto's ThyroiditisStatus unknownNCT02126683Not applicable

← Hydroxychloroquine overview